Teke Zafer, Sacar Mustafa, Yenisey Cigdem, Atalay A Ozgur, Bicakci Tuncay, Erdem Ergun
Department of General Surgery, Pamukkale University, School of Medicine, Denizli, Turkey.
Am J Surg. 2008 Jun;195(6):861-73. doi: 10.1016/j.amjsurg.2007.06.025.
Activated protein C (APC) is a serine protease with anticoagulant and anti-inflammatory activities. APC has been shown to attenuate local deleterious effects of ischemia/reperfusion (I/R) injury in many organs. We aimed to investigate the effects of APC on lung reperfusion injury induced by superior mesenteric occlusion.
Male Wistar-Albino rats were allocated into 4 groups: (1) sham-operated group, laparotomy without I/R injury (n = 12); (2) sham + APC group, identical to group 1 except for APC treatment (n = 12); (3) intestinal I/R group, 60 minutes of ischemia followed by 3 hours of reperfusion (n = 12); and (4) I/R + APC-treated group, 100 microg/kg injection of APC intravenously, 15 minutes before reperfusion (n = 12). Evans blue dye was injected into half of the rats in all groups. We assessed the degree of pulmonary tissue injury by measuring activities of oxidative and antioxidative enzymes, as well as nitrate (NO(3)(-))/nitrite (NO(2)(-)) levels, biochemically. We evaluated acute lung injury (ALI) by establishing pulmonary neutrophil sequestration and ALI scoring histopathologically. Pulmonary edema was estimated by using Evans blue dye extravasation and wet/dry ratios. The plasma levels of proinflammatory cytokines and D-dimer were measured.
APC treatment significantly reduced activities of oxidative enzymes and nitrate/nitrite levels in the lung tissues, and plasma levels of proinflammatory cytokines and D-dimer, and also significantly increased activities of antioxidative enzymes (P < .05). Pulmonary neutrophil sequestration and ALI scores were decreased significantly with APC administration (P < .05). In addition, APC treatment significantly alleviated pulmonary edema (P < .05).
This study clearly showed that APC treatment significantly attenuated the lung reperfusion injury. Further clinical studies are required to clarify whether APC has a useful role in the reperfusion injury during particular surgeries in which I/R-induced organ injury occurs.
活化蛋白C(APC)是一种具有抗凝和抗炎活性的丝氨酸蛋白酶。APC已被证明可减轻许多器官缺血/再灌注(I/R)损伤的局部有害影响。我们旨在研究APC对肠系膜上动脉闭塞所致肺再灌注损伤的影响。
将雄性Wistar白化大鼠分为4组:(1)假手术组,行剖腹术但无I/R损伤(n = 12);(2)假手术+APC组,除接受APC治疗外与第1组相同(n = 12);(3)肠I/R组,缺血60分钟后再灌注3小时(n = 12);(4)I/R + APC治疗组,在再灌注前15分钟静脉注射100μg/kg APC(n = 12)。所有组中一半的大鼠注射伊文思蓝染料。我们通过生化方法测量氧化和抗氧化酶的活性以及硝酸盐(NO₃⁻)/亚硝酸盐(NO₂⁻)水平,评估肺组织损伤程度。我们通过建立肺中性粒细胞滞留并进行组织病理学ALI评分来评估急性肺损伤(ALI)。通过伊文思蓝染料外渗和湿/干比评估肺水肿。测量促炎细胞因子和D-二聚体的血浆水平。
APC治疗显著降低了肺组织中氧化酶的活性以及硝酸盐/亚硝酸盐水平、促炎细胞因子和D-二聚体的血浆水平,还显著增加了抗氧化酶的活性(P <.05)。给予APC后,肺中性粒细胞滞留和ALI评分显著降低(P <.05)。此外,APC治疗显著减轻了肺水肿(P <.05)。
本研究清楚地表明,APC治疗可显著减轻肺再灌注损伤。需要进一步的临床研究来阐明APC在发生I/R诱导器官损伤的特定手术期间的再灌注损伤中是否具有有益作用。